Current treatment of high grade osteosarcoma of the extremity: Review

Journal of Chemotherapy

Volumn 13, Issue 3, 2001, Pages 235-243

  Bacci, G ^a   Lari, S ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Adjuvant and neoadjuvant chemotherapy; Extremity; Limb salvage surgery; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOMYCIN C;

ADJUVANT CHEMOTHERAPY; ARTICLE; DEATH; HUMAN; LIMB AMPUTATION; LIMB SALVAGE; LIMB TUMOR; METASTASIS; OSTEOSARCOMA; PRACTICE GUIDELINE; RECURRENT CANCER;

EID: 0034973064     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.3.235     Document Type: Article

References (48)

1. Doxorubicin in disseminated osteosarcoma
2. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy
3. Amputation and adriamycin in primary osteosarcoma
4. The treatment of osteosarcoma of the extremities: Twenty years' experience at the Istituto Ortopedico Rizzoli
5. Advances and treatment of primary bone tumors
6. Treatment of osteogenic sarcoma. Effect of adjuvant high-dose methotrexate after amputation
7. Methotrexate as adjuvant treatment for primary osteosarcoma
8. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: A randomized study
9. Weekly high dose methotrexate and doxorubicin for osteosarcoma: The Dana Farber Cancer Institute/The Children Hospital-study III
10. Results of the COSS-80 studies on adjuvant chemotherapy in osteosarcoma of the extremities
11. Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response
12. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
13. Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan Kettering experience
14. Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatin, bleomycin, cyclophosphamide, and dactinomycin) for non metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant form
15. Cis-dichlorodiammineplatinum (II) in advanced osteogenic sarcoma
16. Ifosfamide-pharmacology, safety and terapeutic potential
17. Combination chemotherapy with bleomycin, cyclophosphamide, and dactinomycin for the treatment of osteogenic sarcoma
18. Trend and variability in survival among patients with osteosarcoma: A 7-year update
19. The Hypothetical change in the natural history of osteosarcoma: The experience at the Bone Tumor Centre of the Istituto Ortopedico Rizzoli
20. The dilemma of adjuvant chemotherapy for osteogenic sarcoma
21. Dilemma in cancer treatment
22. Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial
23. Multidrug chemotherapy in primary treatment of osteosarcoma
24. Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery
25. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
26. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Ortopedico Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin
27. Treatment of osteosarcoma of the extremities with the T-10 protocol with emphasis on the effects of preoperative chemotherapy with single agent high dose methotrexate: A Scandinavian Sarcoma Group study
28. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children Hospital cancer Group
29. Neoadjuvant chemotherapy for osteogenic sarcoma: Results of a Cooperative German/Austrian study
30. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses methotrexate followed by cisplatin and doxorubicin
31. Long-term results of the Cooperative German/Austrian/Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
32. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup
33. The Children cancer Group (CCG) studies
34. Experience with protocol T-10 in the pediatric service at the Gustave Roussy Institute
35. th study
36. The importance of dose intensity in neoadjuvant chemotherapy of osteosarcoma: A retrospective analysis of high-dose methotrexate, cisplatin, and adriamycin used preoperatively
37. Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma
38. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions
39. Osteogenic sarcoma with detectable metastasis at initial presentation
40. Treatment of metastatic osteosarcoma at diagnosis: A Pediatric Oncology Group study
41. Prognosis of osteosarcoma with pulmonary metastases at initial presentation is not dismal
42. The role of thoracic surgery in the management of metastatic osteogenic sarcoma
43. The surgical treatment of the pulmonary metastases of osteosarcoma on 206 operated cases
44. Examination of prognostic factors after resection of pulmonary metastasis of osteosarcoma by multivariate analysis
45. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival
46. Predictive factors for local recurrence in osteosarcoma: 540 Patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy